Nick is a Policy Advisor for Regulatory Strategy at EFPIA. Nick’s current focus is on the revision of the general pharmaceutical legislation, regulatory science matters, particularly as they relate to the Innovative Health Initiative (IHI), and the interface between the drug, device and diagnostics legislative frameworks in the EU.

Prior to working at EFPIA, Nick spent 25 years at Pfizer within their Global Regulatory Sciences team. His last role in Pfizer was as Head of Europe and International Regulatory Policy. In this role he was also Co-Chair of EFPIA's Regulatory Strategy Committee.

During 2019 Nick was President of TOPRA and Chairman of TOPRA's Board of Directors.

Nick has a graduate degree in Genetics/Microbiology and a master’s degree in Information Science.